Leprosy, Multibacillary
Conditions
Interventions
This is a study divided into three phases. In phase 1, the Delphi method will be applied, which will consist of consulting a panel of experts to obtain consensus on the criteria and guidelines for str
Sponsors
Pro Reitoria de Pesquisa da Universidade Federal de Minas Gerais
Universidade Federal de Minas Gerais
Eligibility
Inclusion criteria
Inclusion criteria: Patients with Leprosy treated at the Hospital das Clínicas of the Federal University of Minas Gerais; both genders; with no minimum or maximum age limit
Exclusion criteria
Exclusion criteria: Patients without Leprosy; patients with Leprosy not treated at the Hospital das Clínicas of the Federal University of Minas Gerais
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| It is expected to observe an improvement in the effectiveness and safety of leprosy pharmacotherapy, assessed through the reduction/disappearance of skin lesions; normalization of the skin’s visual appearance (disappearance of hypochromic, brownish, or reddish spots); reduction/disappearance of motor limitations; normalization of neurological functions (reduction/disappearance of pain); negative conversion/reduction of bacilloscopy with fragmented bacilli; and completion of multidrug therapy doses. Data will be collected during the first pharmacotherapeutic follow-up consultation (intervention) and the last pharmacotherapeutic follow-up consultation (intervention) | — |
Secondary
| Measure | Time frame |
|---|---|
| No secondary outcomes are expected | — |
Countries
Brazil
Contacts
Public ContactMaria Auxiliadora Parreiras Martins
Universidade Federal de Minas Gerais
Outcome results
None listed